19 results
8-K
EX-99.1
SIENQ
Sientra Inc
11 May 23
Sientra Reports Record First Quarter 2023 Operational Results
4:21pm
, California, Sientra is a medical aesthetics company exclusively focused on plastic surgery. The Company mission is to offer proprietary innovations
8-K
EX-99.1
SIENQ
Sientra Inc
30 Mar 23
Sientra Reports Record Fourth Quarter and Full Year Revenues and Expands Total Addressable Market with New Product Launches
4:21pm
surgery. The Company mission is to offer proprietary innovations and unparalleled partnerships that radically advance how plastic surgeons think, work
8-K
EX-99.1
SIENQ
Sientra Inc
10 Nov 22
Sientra Reports Record Third Quarter 2022 Financial Results
4:08pm
, California, Sientra is a medical aesthetics company exclusively focused on plastic surgery. The Company mission is to offer proprietary innovations
8-K
EX-99.2
SIENQ
Sientra Inc
27 Oct 22
Sientra Announces Proposed Public Offering
4:28pm
company exclusively focused on plastic surgery. The Company’s mission is to offer proprietary innovations and unparalleled partnerships that radically
8-K
EX-99.1
al6lp9nhpqtqbn77oz
27 Oct 22
Sientra Announces Proposed Public Offering
4:28pm
8-K
EX-99.1
26bawpoxfb 5a79uw7
12 Oct 22
Sientra Announces Preliminary Unaudited Third Quarter Financial
9:06am
8-K
EX-99.1
7xol pn6coxz
11 Aug 22
Sientra Reports Second Quarter Revenue Growth Driven By Increased Acceleration in Reconstruction Channel
4:07pm
8-K
EX-99.1
qbi48hnn bzqvqn
12 May 22
Sientra Reports Seventh Consecutive Quarter of Record Growth for First Quarter 2022
4:09pm
8-K
EX-99.1
32y61e9ex
24 Mar 22
Sientra Receives Regulatory Approval to Market Breast Implants in Canada
8:56pm
8-K
EX-99.1
r848nvob i4fgcn
23 Mar 22
Sientra Reports Record Plastic Surgery Revenue for Both Fourth Quarter and Full Year 2021
4:37pm
8-K
EX-99.1
qnxnsviegx24wtaxbbnu
10 Jan 22
Sientra Reports Record Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenues
9:02am
8-K
EX-99.1
uc65m
10 Nov 21
Sientra Reports Record Third Quarter 2021 Revenue for Continuing Operations Revenue growth of 28% Year Over Year
4:30pm
8-K
EX-99.1
r89va2gpp7firle 7r
10 Aug 21
Sientra Reports Record Breast Products Revenue for Second Quarter 2021
4:06pm
8-K
EX-99.2
t1gxatrgrlm5p9oof70i
16 Jun 21
Unaudited Pro Forma Financial Statements
4:01pm
8-K
EX-99.1
6fspn50o
11 May 21
Sientra Announces Sale of miraDry Business to 1315 Capital
4:47pm
8-K
EX-99.1
a69tg9nk79mt
11 May 21
Sientra Reports Record First Quarter 2021 Financial Results
4:10pm
8-K
EX-99.1
ml4jg3turp3vitkx
21 Mar 19
Sientra® Issues Statement in Response to FDA Post-Approval Study Warning Letter
4:40pm
- Prev
- 1
- Next